Search

everythinglearnresearchcommunity

for

Search:↓

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Loss of Dnmt3a and Dnmt3b leads to more aggressive skin tumors, but blocking PPAR-γ can reduce this effect.

Neuropilin 2 may be a biomarker for melanoma and affects melanocyte behavior.

Men with melanoma have a higher risk of later being diagnosed with prostate cancer.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

An automated method accurately assesses melanoma risk using 3D body images to analyze skin traits.

A woman got melanoma on her scalp after anti-hair loss treatment with injections.

Nano-Pulse Stimulation™ Therapy is more effective and less damaging than cryoablation for treating melanoma tumors in mice.

Scalp melanomas are more dangerous and often missed, needing earlier detection.

Moles on the scalp are more common in people with more body moles and atypical moles, but not linked to balding.

Lentiginous melanoma is most common on the face, especially the nose, cheek, and pre-auricular areas, with men more likely to have it on the scalp, ears, upper back, and trapezius, and women on the cheek and anterior arm. Sun damage is a key factor in its formation.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Scalp melanomas are more dangerous and likely to recur or cause death than other head and neck melanomas.

Melanocytic matricoma can look like skin cancer but is usually harmless; surgery and follow-up are advised.

PRAME helps distinguish between benign and malignant skin cells in most cases.

Peanut agglutinin staining helps differentiate malignant melanoma from nevocellular nevus.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Researchers discovered potential origins and new treatments for skin cancer, including biomarkers for melanoma and therapies that reduce tumor growth.

Blood pressure medications may increase the risk of skin cancer.

Scalp melanoma is often diagnosed late in people with hair loss, leading to worse outcomes.

Finasteride and dutasteride may lower melanoma risk, with teenage acne possibly indicating higher risk.

Keratinocytes can reverse the effects of the GNAQ oncogene, inhibiting melanoma cell growth.

NLRP1 helps melanoma tumors grow by boosting inflammasome activation and reducing caspase-3 activity.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

Melanoma survivors are more likely to use sunscreen and seek shade than others, but less than half often use sunscreen and avoid the sun, and some still use tanning beds.

The microenvironment affects the behavior and survival of melanocytes with the GNAQ oncogene in melanoma.

A 12-year-old girl was misdiagnosed with alopecia areata but actually had a nevus sebaceus with a genetic mutation.